Ib Jarle Christensen

Ib Jarle Christensen's AcademicInfluence.com Rankings

Computer Science

#5755

World Rank

#6074

Historical Rank

Computational Linguistics

#873

World Rank

#886

Historical Rank

Machine Learning

#1640

World Rank

#1662

Historical Rank

Artificial Intelligence

#1877

World Rank

#1909

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Why Is Ib Jarle Christensen Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ib Jarle Christensen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. (1983) (1738)
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. (2002) (619)
Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry. (2010) (515)
High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. (1993) (431)
Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards. (1983) (398)
Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis. (1999) (296)
Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model (2005) (295)
High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients (2010) (276)
Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma. (2009) (275)
Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer. (1989) (249)
A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric DNA analysis. (1990) (244)
Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue (1999) (244)
Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma (2012) (227)
Limits of detection of nuclear DNA abnormalities by flow cytometric DNA analysis. Results obtained by a set of methods for sample-storage, staining and internal standardization. (1983) (219)
Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass. (2012) (202)
Serum YKL-40 and colorectal cancer (1999) (189)
Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis. (2000) (186)
Clonal heterogeneity of small-cell anaplastic carcinoma of the lung demonstrated by flow-cytometric DNA analysis. (1980) (183)
The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer (2015) (181)
MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer - a multicenter prospective comparative study. (2013) (180)
Long-term storage of samples for flow cytometric DNA analysis. (1983) (179)
High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer. (2000) (167)
Syncytin is involved in breast cancer-endothelial cell fusions (2006) (157)
Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer (1999) (155)
A phase I clinical trial of the histone deacetylase inhibitor belinostat in patients with advanced hematological neoplasia (2008) (153)
Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort. (2014) (152)
Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets (2002) (151)
Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer. (2002) (144)
High serum YKL‐40 level after surgery for colorectal carcinoma is related to short survival (2002) (139)
A nationwide cohort study of stage I seminoma patients followed on a surveillance program. (2014) (139)
High serum YKL-40 level in patients with small cell lung cancer is related to early death. (2004) (134)
Plasminogen activation independent of uPA and tPA maintains wound healing in gene‐deficient mice (2006) (132)
High Serum YKL-40 Levels in Patients with Primary Breast Cancer is Related to Short Recurrence Free Survival (2003) (129)
Lactational competence and involution of the mouse mammary gland require plasminogen. (2000) (125)
Postoperative medical complications are the main cause of early death after emergency surgery for colonic cancer (2008) (124)
Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer (2000) (122)
Tissue inhibitor of metalloproteinases-1 in breast cancer. (2005) (119)
Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma (2002) (114)
Prognostic significance of soluble urokinase plasminogen activator receptor in serum and cytosol of tumor tissue from patients with primary breast cancer. (2002) (111)
In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin. (1997) (110)
Histone deacetylase 1, 2, 6 and acetylated histone H4 in B‐ and T‐cell lymphomas (2009) (107)
Prognostic value of PINP, bone alkaline phosphatase, CTX‐I, and YKL‐40 in patients with metastatic prostate carcinoma (2006) (103)
Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study (2000) (103)
Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study. (2007) (101)
Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group. (2000) (97)
Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma (2008) (97)
Deficiency of mannan-binding lectin associated serine protease-2 due to missense polymorphisms (2007) (93)
Serum levels of YKL-40 increases in patients with acute myocardial infarction (2008) (89)
Association between plasma concentrations of plasminogen activator inhibitor-1 and survival in patients with colorectal cancer (1998) (86)
Multiplexed Homogeneous Proximity Ligation Assays for High-throughput Protein Biomarker Research in Serological Material* (2011) (85)
TIMP-1 Is Significantly Associated with Objective Response and Survival in Metastatic Colorectal Cancer Patients Receiving Combination of Irinotecan, 5-Fluorouracil, and Folinic Acid (2007) (84)
Tumor Tissue Concentrations of the Proteinase Inhibitors Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and Plasminogen Activator Inhibitor Type 1 (PAI-1) Are Complementary in Determining Prognosis in Primary Breast Cancer * (2003) (82)
Pre-analytical and biological variability in circulating interleukin 6 in healthy subjects and patients with rheumatoid arthritis (2008) (82)
Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia (2015) (81)
Primary Tumor Levels of Tissue Inhibitor of Metalloproteinases-1 Are Predictive of Resistance to Chemotherapy in Patients with Metastatic Breast Cancer (2006) (80)
Steroid levels in ovarian follicular fluid related to follicle size and health status during the normal menstrual cycle in women. (1986) (80)
Increased activity of the mannan‐binding lectin complement activation pathway in patients with colorectal cancer (2004) (79)
Elevated plasma levels of vascular endothelial growth factor and plasminogen activator inhibitor-1 decrease during improvement of psoriasis (2002) (79)
Soluble Urokinase Plasminogen Activator Receptor Measurements: Influence of Sample Handling (2001) (79)
Detergent and proteolytic enzyme-based techniques for nuclear isolation and DNA content analysis. (1994) (79)
DNA ploidy-characteristics of human malignant melanoma analysed by flow cytometry and compared with histology and clinical course (1983) (77)
Plasma TIMP-1 and CEA in detection of primary colorectal cancer: a prospective, population based study of 4509 high-risk individuals (2011) (77)
Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer. (1998) (76)
TIMP-1 gene deficiency increases tumour cell sensitivity to chemotherapy-induced apoptosis (2006) (75)
A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer - An international multicenter study in women with an ovarian mass. (2015) (75)
Serum YKL-40 predicts relapse-free and overall survival in patients with American Joint Committee on Cancer stage I and II melanoma. (2006) (75)
Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution (2013) (73)
uPAR as anti-cancer target: evaluation of biomarker potential, histological localization, and antibody-based therapy. (2011) (73)
The association of reduced folate carrier 80G>A polymorphism to outcome in childhood acute lymphoblastic leukemia interacts with chromosome 21 copy number. (2010) (72)
Cleaved Forms of the Urokinase Plasminogen Activator Receptor in Plasma Have Diagnostic Potential and Predict Postoperative Survival in Patients with Ovarian Cancer (2008) (72)
YKL-40 tissue expression and plasma levels in patients with ovarian cancer (2009) (72)
Diurnal, Weekly, and Long-Time Variation in Serum Concentrations of YKL-40 in Healthy Subjects (2008) (71)
Immunocytochemical detection of progesterone receptor in breast cancer with monoclonal antibody. Relation to biochemical assay, disease‐free survival, and clinical endocrine response (1988) (70)
Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model. (2001) (70)
Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer—a clinical biomarker discovery and validation study (2019) (69)
An integrated set of methods for routine flow cytometric DNA analysis. (1990) (69)
Attenuated familial adenomatous polyposis: results from an international collaborative study (2010) (68)
Frequencies and Prognostic Role of KRAS and BRAF Mutations in Patients With Localized Pancreatic and Ampullary Adenocarcinomas (2012) (68)
Biological Variation in Circulating Levels of Mannan‐Binding Lectin (MBL) and MBL‐Associated Serine Protease‐2 and the Influence of Age, Gender and Physical Exercise (2007) (68)
Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survival. a validation study. (2004) (67)
HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET) (2013) (65)
Growth pattern of colorectal liver metastasis as a marker of recurrence risk (2015) (63)
Short recurrence-free survival associated with high oestrogen receptor levels in the natural history of postmenopausal, primary breast cancer. (1993) (62)
Estramustine phosphate versus placebo as second line treatment after orchiectomy in patients with metastatic prostate cancer: DAPROCA study 9002. Danish Prostatic Cancer Group. (1997) (61)
Duodenal surveillance improves the prognosis after duodenal cancer in familial adenomatous polyposis (2012) (61)
The urokinase plasminogen activator receptor in blood from healthy individuals and patients with cancer (1999) (61)
Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel-platinum. (2005) (60)
Influence of major surgery on the mannan‐binding lectin pathway of innate immunity (2006) (60)
Colectomy and Ileorectal Anastomosis is still an Option for Selected Patients with Familial Adenomatous Polyposis (2008) (59)
Changes of Biochemical Markers of Bone Turnover and YKL-40 Following Hormonal Treatment for Metastatic Prostate Cancer Are Related to Survival (2007) (58)
Does neoadjuvant chemotherapy impair long-term survival for ovarian cancer patients? A nationwide Danish study. (2014) (58)
Prognostic role of syncytin expression in breast cancer. (2007) (57)
Preoperative plasma TIMP-1 is an independent prognostic indicator in patients with primary colorectal cancer: a prospective validation study. (2010) (54)
Histopathological Growth Pattern, Proteolysis and Angiogenesis in Chemonaive Patients Resected for Multiple Colorectal Liver Metastases (2012) (54)
Enhanced discrimination of benign from malignant prostatic disease by selective measurements of cleaved forms of urokinase receptor in serum. (2006) (53)
Prognostic value of intact and cleaved forms of the urokinase plasminogen activator receptor in a retrospective study of 518 colorectal cancer patients (2010) (52)
A precise and efficient stereological method for determining murine lung metastasis volumes. (2001) (52)
Data fusion in metabolomic cancer diagnostics (2012) (52)
Syncytin immunoreactivity in colorectal cancer: potential prognostic impact. (2009) (52)
Prognostic and predictive value of intact and cleaved forms of the urokinase plasminogen activator receptor in metastatic prostate cancer (2011) (51)
Circulating VEGF As a Biological Marker in Patients with Rheumatoid Arthritis? Preanalytical and Biological Variability in Healthy Persons and in Patients (2007) (50)
Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma. (2008) (50)
Ranitidine as adjuvant treatment in colorectal cancer (2002) (50)
The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma (2016) (50)
SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients. (2013) (49)
Tissue inhibitor of metalloproteinases-1 in the postoperative monitoring of colorectal cancer. (2006) (49)
High serum levels of YKL‐40 in patients with squamous cell carcinoma of the head and neck are associated with short survival (2008) (49)
Serum testosterone as a prognostic factor in patients with advanced prostatic carcinoma. (1994) (48)
Extracellular protease mRNAs are predominantly expressed in the stromal areas of microdissected mouse breast carcinomas. (2005) (48)
Urokinase-type plasminogen activator receptor (uPAR) on tumor-associated macrophages is a marker of poor prognosis in colorectal cancer (2014) (47)
Prognostic importance of the soluble plasminogen activator receptor, suPAR, in plasma from rectal cancer patients. (2001) (47)
The liberated domain I of urokinase plasminogen activator receptor – a new tumour marker in small cell lung cancer (2013) (47)
Effects of the antioestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF-7. (1984) (47)
Centralized treatment of advanced stages of ovarian cancer improves survival: a nationwide Danish survey (2010) (47)
Long‐term results of danish prostatic cancer group trial 86. Goserelin acetate plus flutamide versus orchiectomy in advanced prostate cancer (1993) (46)
Urokinase plasminogen activator receptor on invasive cancer cells: A prognostic factor in distal gastric adenocarcinoma (2012) (46)
Comorbidity is an independent prognostic factor for the survival of ovarian cancer: a Danish register-based cohort study from a clinical database. (2013) (46)
Differential cytotoxicity of 19 anticancer agents in wild type and etoposide resistant small cell lung cancer cell lines. (1993) (46)
Fluorescence spectroscopy as a potential metabonomic tool for early detection of colorectal cancer (2012) (45)
Serum interleukin-6 as a prognostic biomarker in patients with metastatic melanoma (2012) (44)
Plasminogen activator inhibitor type 1 in cytosolic tumor extracts predicts prognosis in low-risk breast cancer patients. (1997) (44)
Serum YKL-40 in Risk Assessment for Colorectal Cancer: A Prospective Study of 4,496 Subjects at Risk of Colorectal Cancer (2015) (44)
Hydatidiform Mole and Fetus With Normal Karyotype: Support of a Separate Entity (1991) (44)
Flow cytometric DNA ploidy defines patients with poor prognosis in node‐negative breast cancer (2007) (43)
Prospective evaluation of angiogenic, hypoxic and EGFR‐related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan (2010) (43)
The complex between urokinase and its type-1 inhibitor in primary breast cancer: relation to survival. (2000) (42)
Endothelial cell nitric oxide synthase in peritumoral microvessels is a favorable prognostic indicator in premenopausal breast cancer patients. (1999) (42)
A randomized pilot study on single-port versus conventional laparoscopic rectal surgery: effects on postoperative pain and the stress response to surgery (2014) (42)
NOD2/CARD15 Gene Polymorphisms in Crohn’s Disease: A Genotype-Phenotype Analysis in Danish and Portuguese Patients and Controls (2005) (42)
Follow-Up of Exocrine Pancreatic Function in Type-1 Diabetes mellitus (2005) (41)
Detection of serological biomarkers by proximity extension assay for detection of colorectal neoplasias in symptomatic individuals (2013) (40)
Plasma tissue inhibitor of metalloproteinases-1 as a biological marker? Pre-analytical considerations. (2007) (38)
Estrogen Receptor analyses in the Danish Breast Cancer Cooperative Group. History, methods, prognosis and clinical implications (2008) (38)
Prognostic factors in neuroblastomas treated in denmark from 1943 to 1980: A statistical estimate of prognosis based on 253 cases (1986) (38)
Double role of mannose-binding lectin in relation to carotid intima-media thickness in patients with rheumatoid arthritis. (2010) (37)
Preoperative mannan-binding lectin pathway and prognosis in colorectal cancer (2005) (37)
Washless double staining of unfixed nuclei for flow cytometric analysis of DNA and a nuclear antigen (Ki-67 or bromodeoxyuridine). (1991) (37)
Delayed dental maturity in dentitions with agenesis of mandibular second premolars. (2010) (36)
Prognostic impact of liberated domain I of the urokinase plasminogen activator receptor in squamous cell lung cancer tissue. (2005) (36)
Plasma TIMP-1 in patients with colorectal adenomas: a prospective study. (2004) (35)
Zoladex and Flutamide Versus Orchiectomy in the Treatment of Advanced Prostatic Cancer (1990) (35)
A new assay for measurement of the liberated domain I of the urokinase receptor in plasma improves the prediction of survival in colorectal cancer. (2010) (35)
Detection of colorectal neoplasia: Combination of eight blood‐based, cancer‐associated protein biomarkers (2017) (35)
Urokinase receptor forms in serum from non-small cell lung cancer patients: relation to prognosis. (2010) (35)
Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancer (2008) (35)
Flow cytometric DNA analysis of lesions from 18 children with langerhans cell histiocytosis (histiocytosis x). (1990) (34)
Prognostic significance of urokinase plasminogen activator receptor and its cleaved forms in blood from patients with non‐small cell lung cancer (2009) (34)
Fractionated stereotactic radiotherapy of vestibular schwannomas accelerates hearing loss. (2012) (34)
Prognosis in adenocarcinomas of lower oesophagus, gastro‐oesophageal junction and cardia evaluated by uPAR‐immunohistochemistry (2012) (33)
Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases. (2001) (33)
Matrix Metalloproteinase 13 Is Induced in Fibroblasts in Polyomavirus Middle T Antigen-Driven Mammary Carcinoma without Influencing Tumor Progression (2008) (32)
Measurement of the noncomplexed free fraction of tissue inhibitor of metalloproteinases 1 in plasma by immunoassay. (2002) (32)
Progesterone receptor levels independently predict survival in endometrial adenocarcinoma. (1995) (32)
Biopsy-verified bronchiolitis obliterans and other noninfectious lung pathologies after allogeneic hematopoietic stem cell transplantation. (2015) (32)
Relapse and disease specific survival in 1143 Danish women diagnosed with borderline ovarian tumours (BOT). (2016) (32)
Varying involvement of peripheral granulocytes in the clonal abnormality - 7 in bone marrow cells in preleukemia secondary to treatment of other malignant tumors: cytogenetic results compared with results of flow cytometric DNA analysis and neutrophil chemotaxis. (1982) (32)
Serum testosterone level as a predictor of biochemical failure after radical prostatectomy for localized prostate cancer (2012) (32)
Identification and validation of potential prognostic and predictive miRNAs of epithelial ovarian cancer (2018) (32)
The cytotoxic activity of cisplatin, carboplatin and teniposide alone and combined determined on four human small cell lung cancer cell lines by the clonogenic assay. (1988) (31)
Gastrointestinal Toxicity, Systemic Inflammation, and Liver Biochemistry in Allogeneic Hematopoietic Stem Cell Transplantation. (2017) (31)
The complex between urokinase (uPA) and its type-1 inhibitor (PAI-1) in pulmonary adenocarcinoma: relation to prognosis. (2006) (31)
Early diagnosis of cutaneous T‐cell lymphoma by DNA flow cytometry on skin biopsies (1984) (31)
The prognostic value of dividing epithelial ovarian cancer into type I and type II tumors based on pathologic characteristics. (2015) (31)
Indication of a role of plasminogen activator inhibitor type 1 in protecting murine fibrosarcoma cells against apoptosis (2005) (30)
The association between preoperative concentration of soluble vascular endothelial growth factor, perioperative blood transfusion, and survival in patients with primary colorectal cancer. (2001) (30)
DNA ploidy in colorectal cancer, heterogeneity within and between tumors and relation to survival. (1999) (30)
A novel proteomic biomarker panel as a diagnostic tool for patients with ovarian cancer. (2011) (29)
Expression level of Wilms tumor 1 (WT1) protein has limited prognostic value in epithelial ovarian cancer: from the Danish "MALOVA" ovarian cancer study. (2007) (29)
Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer (2013) (29)
DNA flow cytometry on human epidermis: I. methodological studies on normal skin. (1980) (29)
Prognostic value of different staging systems in neuroblastomas and completeness of tumour excision. (1986) (28)
Mannan‐Binding Lectin (MBL) and MBL‐Associated Serine Protease 2 (MASP‐2) Genotypes in Colorectal Cancer (2011) (28)
SOX9 expression predicts relapse of stage II colon cancer patients. (2016) (28)
Proteomic biomarkers for overall and progression‐free survival in ovarian cancer patients (2010) (28)
Carcinoma in situ of the breast: correlation of histopathology to immunohistochemical markers and DNA ploidy (2000) (28)
Pre- and postoperative levels in serum of mannan-binding lectin associated serine protease-2 -a prognostic marker in colorectal cancer. (2008) (27)
Renal impairment and late toxicity in germ-cell cancer survivors. (2015) (27)
Sagittal, vertical and transversal dimensions of the maxillary complex in patients with ectopic maxillary canines. (2010) (27)
Comparison of proteomic biomarker panels in urine and serum for ovarian cancer diagnosis (2010) (27)
Serum cathepsin H as a potential prognostic marker in patients with colorectal cancer. (2004) (27)
Quantification of Tissue Inhibitor of Metalloproteinases 2 in Plasma from Healthy Donors and Cancer Patients (2005) (27)
Assessment of the biological variation of plasma tissue inhibitor of metalloproteinases-1. (2008) (27)
Sequential Versus Combined Treatment of Human Breast Cancer Cells with Antiestrogens and the Vitamin D Analogue EB1089 and Evaluation of Predictive Markers for Vitamin D Treatment (2004) (27)
Measurement of the Uncomplexed Fraction of Tissue Inhibitor of Metalloproteinases-1 in the Prognostic Evaluation of Primary Breast Cancer Patients* (2005) (27)
High Plasma TIMP-1 and Serum CEA Levels during Combination Chemotherapy for Metastatic Colorectal Cancer Are Significantly Associated with Poor Outcome (2010) (26)
Intact and cleaved forms of the urokinase receptor enhance discrimination of cancer from non-malignant conditions in patients presenting with symptoms related to colorectal cancer (2009) (26)
Prognostic stratification of ulcerated melanoma: not only the extent matters. (2014) (26)
Screening for colorectal cancer: possible improvements by risk assessment evaluation? (2011) (26)
DNA ploidy and S-phase fraction in primary breast carcinomas in relation to prognostic factors and survival for premenopausal patients at high risk for recurrent disease. (1988) (26)
Urokinase-type plasminogen activator receptor (uPAR) expression is associated with T-stage and survival in urothelial carcinoma of the bladder. (2015) (26)
Evaluation of and quality assurance in HER2 analysis in breast carcinomas from patients registered in Danish Breast Cancer Group (DBCG) in the period of 2002–2006. A nationwide study including correlation between HER-2 status and other prognostic variables (2008) (25)
Survival of ovarian cancer patients in Denmark: Results from the Danish gynaecological cancer group (DGCG) database, 1995–2012 (2016) (25)
Circulating Vascular Endothelial Growth Factor Six Months after Primary Surgery as a Prognostic Marker in Patients with Colorectal Cancer (2003) (25)
Plasma TIMP-1 and CEA as Markers for Detection of Primary Colorectal Cancer: A Prospective Validation Study Including Symptomatic and Non-symptomatic Individuals. (2015) (25)
Predicting lower third molar eruption on panoramic radiographs after cephalometric comparison of profile and panoramic radiographs. (2013) (25)
Prospective multi-centre randomised trial comparing induction of labour with a double-balloon catheter versus dinoprostone (2015) (25)
Assessment of Quantitative and Allelic MGMT Methylation Patterns as a Prognostic Marker in Glioblastoma (2016) (25)
Mechanisms of Topoisomerase I (TOP1) Gene Copy Number Increase in a Stage III Colorectal Cancer Patient Cohort (2013) (24)
Impact of elective resection on plasma TIMP‐1 levels in patients with colon cancer (2006) (24)
Prognostic value of cytosolic thymidine kinase activity as a marker of proliferation in breast cancer. (1995) (24)
Malignant transformation of wild-type but not plasminogen activator inhibitor-1 gene-deficient fibroblasts decreases cellular sensitivity to chemotherapy-mediated apoptosis. (2005) (23)
Identification of predictive biomarkers for the histone deacetylase inhibitor belinostat in a panel of human cancer cell lines. (2008) (23)
Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer. (2011) (23)
Survival after radical prostatectomy for clinically localised prostate cancer: a population‐based study (2014) (23)
Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer: long-term follow-up of the SPCG-6 study. (2015) (23)
Risk factors for brain metastases in patients with metastatic colorectal cancer (2016) (22)
Risk of recurrence, prognosis, and follow‐up for Danish women with cervical cancer in 2005‐2013: A national cohort study (2018) (22)
DNA aneuploidy in early breast cancer. (1995) (22)
Ly6/uPAR-Related Protein C4.4A as a Marker of Solid Growth Pattern and Poor Prognosis in Lung Adenocarcinoma (2013) (22)
Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients (2016) (22)
Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer (2017) (21)
Topoisomerase 1(TOP1) gene copy number in stage III colorectal cancer patients and its relation to prognosis (2013) (21)
Flow cytometric discrimination of mitotic cells (1983) (21)
High expression of endothelial cell nitric oxide synthase in peritumoral microvessels predicts increased disease-free survival in colorectal cancer. (2004) (21)
Association between tumor tissue TIMP-1 levels and objective response to first-line chemotherapy in metastatic breast cancer (2010) (21)
Assessing genetic markers of tumour progression in the context of intratumour heterogeneity. (1998) (21)
Plasma YKL-40 in Patients with Metastatic Colorectal Cancer Treated with First Line Oxaliplatin-Based Regimen with or without Cetuximab: RESULTS from the NORDIC VII Study (2014) (21)
Validation of epithelial ovarian cancer and fallopian tube cancer and ovarian borderline tumor data in the Danish Gynecological Cancer Database (2009) (21)
Tissue disaggregation for flow cytometric DNA analysis: comparison of fine-needle aspiration and an automated mechanical procedure. (1996) (21)
Diagnostic plasma miRNA-profiles for ovarian cancer in patients with pelvic mass (2019) (20)
Preoperative CA125 as a prognostic factor in stage I epithelial ovarian cancer (2006) (20)
Toxicity and efficacy of lomustine and bevacizumab in recurrent glioblastoma patients (2018) (20)
Influence of open versus laparoscopically assisted colectomy on soluble vascular endothelial growth factor (sVEGF) and its soluble receptor 1 (sVEGFR1) (2005) (20)
Cathepsin X in serum from patients with colorectal cancer: relation to prognosis (2012) (20)
Prognostic Significance of Interleukin-7 Receptor-&agr; Gene Polymorphisms in Allogeneic Stem-Cell Transplantation: A Confirmatory Study (2011) (19)
Prognostic and predictive value of YKL-40 in stage IIB-III melanoma (2016) (19)
A novel prognostic index in colorectal cancer defined by serum carcinoembryonic antigen and plasma tissue inhibitor of metalloproteinases-1 (2010) (19)
A novel index for preoperative, non-invasive prediction of macro-radical primary surgery in patients with stage IIIC–IV ovarian cancer—a part of the Danish prospective pelvic mass study (2016) (19)
Is stabilization of disease a useful indicator for survival in second-line treatment of ovarian carcinoma pre-treated with Paclitaxel-Platinum? (2004) (18)
Pretransplant C‐reactive Protein as A Prognostic Marker in Allogeneic Stem Cell Transplantation (2014) (18)
Lung function after allogeneic hematopoietic stem cell transplantation in children: a longitudinal study in a population-based cohort. (2013) (18)
Evaluation of complement proteins as screening markers for colorectal cancer (2014) (18)
The Prognostic and Predictive Value of Soluble Type IV Collagen in Colorectal Cancer: A Retrospective Multicenter Study (2015) (18)
Inflammation and uPAR-Expression in Colorectal Liver Metastases in Relation to Growth Pattern and Neo-adjuvant Therapy (2015) (18)
Measuring ERCC1 protein expression in cancer specimens: Validation of a novel antibody (2014) (18)
Assessment of the topoisomerase I gene copy number as a predictive biomarker of objective response to irinotecan in metastatic colorectal cancer (2013) (18)
Microvessel density and endothelial cell proliferation levels in colorectal liver metastases from patients given neo‐adjuvant cytotoxic chemotherapy and bevacizumab (2016) (18)
Flow cytometric deoxyribonucleic acid analysis of granulosa cells aspirated from human ovarian follicles. A new method to distinguish healthy and atretic ovarian follicles. (1982) (18)
Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer; A randomized trial of tamoxifen vs. tamoxifen + aminoglutethimide and hydrocortisone and tamoxifen + fluoxymesterone in women above 65 years of age (2000) (17)
Decline in CA19-9 during chemotherapy predicts survival in four independent cohorts of patients with inoperable bile duct cancer. (2015) (17)
Concomitant lack of MMP9 and uPA disturbs physiological tissue remodeling. (2011) (17)
Survival and toxicity in patients with disseminated germ cell cancer aged 40 years and older (2014) (17)
Pre-treatment prediction of chemoresistance in second-line chemotherapy of ovarian carcinoma: value of serological tumor marker determination (tetranectin, YKL-40, CASA, CA 125). (2006) (17)
Mandibular advancement device therapy for obstructive sleep apnea: a prospective study on predictors of treatment success. (2019) (17)
Preoperative plasma soluble urokinase plasminogen activator receptor as a prognostic marker in rectal cancer patients. An EORTC-Receptor and Biomarker Group collaboration. (2005) (17)
Prognostic and predictive value of cathepsin X in serum from colorectal cancer patients (2014) (16)
Levels of tissue inhibitor of metalloproteinases-1 in blood transfusion components (2002) (16)
Synchronization of the Human Promyelocytic Cell Line HL 60 By Thymidine (1986) (16)
Digital image analysis of pan-cytokeratin stained tumor slides for evaluation of tumor budding in pT1/pT2 colorectal cancer: Results of a feasibility study. (2018) (16)
Cell cycle analysis of estrogen stimulation and antiestrogen inhibition of growth of the human breast cancer cell line MCF-7. (1986) (15)
uPAR Expression Pattern in Patients with Urothelial Carcinoma of the Bladder – Possible Clinical Implications (2015) (15)
Prognostic significance of DNA content in bladder cancer based on flow cytometric analysis of 249 transitional cell carcinomas. (1995) (15)
A Comparative Study of Tissue Inhibitor of Metalloproteinases-1 Levels in Plasma and Tumour Tissue from Patients with Primary Breast Cancer and in Plasma from Patients with Metastatic Breast Cancer (2008) (15)
Prognostic value of cytosolic thymidine kinase activity as a marker of proliferation in breast cancer (1995) (15)
Flow cytometric DNA analyses of 105 fresh hydatidiform moles, with correlations to prognosis. (1996) (15)
Prognostic value of tissue protein expression levels of MIB‐1 (Ki‐67) in Danish ovarian cancer patients. From the ‘MALOVA’ ovarian cancer study (2013) (15)
Phase II trial of erlotinib and bevacizumab in patients with advanced upper gastrointestinal cancers (2012) (14)
Flow sorting of mouse pancreatic B cells by forward and orthogonal light scattering. (1982) (14)
Protocol Outlines for Parts 1 and 2 of the Prospective Endoscopy III Study for the Early Detection of Colorectal Cancer: Validation of a Concept Based on Blood Biomarkers (2016) (14)
A new clinically applicable age-specific comorbidity index for preoperative risk assessment of ovarian cancer patients. (2016) (14)
A five-factor biomarker profile obtained week 4–12 of treatment for improved prognostication in metastatic renal cell carcinoma: Results from DARENCA study 2 (2015) (14)
Repeated biopsies in patients with prostate cancer on active surveillance: clinical implications of interobserver variation in histopathological assessment (2015) (14)
Prostate‐specific antigen doubling time as a progression criterion in an active surveillance programme for patients with localized prostate cancer (2014) (14)
Changes in plasma TIMP-1 levels after resection for primary colorectal cancer. (2009) (14)
Intra-tumor heterogeneity of microRNA-92a, microRNA-375 and microRNA-424 in colorectal cancer. (2016) (14)
Discrimination of bromodeoxyuridine labelled and unlabelled mitotic cells in flow cytometric bromodeoxyuridine/DNA analysis. (1994) (14)
Circulating intact and cleaved forms of the urokinase-type plasminogen activator receptor: biological variation, reference intervals and clinical useful cut-points. (2015) (13)
Survival outcomes in patients with cervical cancer after inclusion of PET/CT in staging procedures (2015) (13)
Changes in soluble CEA and TIMP-1 levels during adjuvant chemotherapy for stage III colon cancer. (2010) (13)
Serum tetranectin is an independent prognostic marker in colorectal cancer and weakly correlated with plasma suPAR, plasma PAI‐1 and serum CEA (2002) (13)
Characterization of a human breast cancer cell line, MCF-7/RU58R-1, resistant to the pure antiestrogen RU 58,668 (2005) (13)
Steroid concentrations in fluid from human ovarian antral follicles during pregnancy. (1985) (13)
YKL‐40 protein in osteosarcoma tumor tissue (2016) (13)
Preoperative Plasma Soluble Urokinase Plasminogen Activator Receptor as a Prognostic Marker in Rectal Cancer Patients. An Eortc-Receptor and Biomarker Group Collaboration (2005) (13)
Positron emission tomography/computed tomography and biomarkers for early treatment response evaluation in metastatic colon cancer. (2014) (13)
Differences between dentitions with palatally and labially located maxillary canines observed in incisor width, dental morphology and space conditions. (2010) (13)
Topoisomerase‐1 gene copy aberrations are frequent in patients with breast cancer (2015) (13)
The effect of the two epipodophyllotoxin derivatives etoposide (VP-16) and teniposide (VM-26) on cell lines established from patients with small cell carcinoma of the lung (2004) (13)
DNA analysis by flow cytometry in cutaneous T‐cell lymphomas (1989) (13)
Preoperative Mannan‐Binding Lectin Pathway and Prognosis in Colorectal Cancer (2004) (13)
Prognostic and Clinicopathologic Associations of LAG-3 Expression in Triple-negative Breast Cancer (2021) (13)
IQGAP1 in rectal adenocarcinomas: localization and protein expression before and after radiochemotherapy. (2015) (12)
Sample handling for mass spectrometric proteomic investigations of human urine (2008) (12)
Clinical validation of chemotherapy predictors developed on global microRNA expression in the NCI60 cell line panel tested in ovarian cancer (2017) (12)
Aneuploidy in cutaneous T-cell lymphoma. (1983) (12)
DNA aneuploidy in gastric carcinoma. Flow cytometric data related to survival, location, and histopathologic findings. (1995) (12)
Circulating tyrosinase and MART-1 mRNA does not independently predict relapse or survival in patients with AJCC stage I-II melanoma. (2006) (12)
Early metastatic colorectal cancers show increased tissue expression of miR-17/92 cluster members in the invasive tumor front. (2018) (12)
Copenhagen uPAR prostate cancer (CuPCa) database: protocol and early results. (2016) (12)
Discovery and Validation of Plasma-Protein Biomarker Panels for the Detection of Colorectal Cancer and Advanced Adenoma in a Danish Collection of Samples from Patients Referred for Diagnostic Colonoscopy. (2016) (12)
On circadian rhythms in human epidermal cell proliferation. (1991) (12)
Signs, symptoms, metastatic spread and metabolic behavior of neuroblastomas treated in Denmark during the period 1943-1980. (1987) (12)
DNA analysis of in situ ductal carcinoma of the breast via flow cytometry. (1995) (12)
Type I Versus Type II Endometrial Cancer: Differential Impact of Comorbidity (2018) (12)
Preoperative serum tetranectin, CA125 and menopausal status used as single markers in screening and in a risk assessment index (RAI) in discriminating between benign and malignant ovarian tumors. (2009) (12)
Risk of biochemical recurrence and positive surgical margins in patients with pT2 prostate cancer undergoing radical prostatectomy (2014) (11)
Some methods and applications of flow cytometric DNA analysis in clinical and experimental oncology (1989) (11)
Risk factors associated with positive surgical margins following radical prostatectomy for clinically localized prostate cancer: Can nerve-sparing surgery increase the risk? (2014) (11)
Fever and the use of paracetamol during IL-2-based immunotherapy in metastatic melanoma (2015) (11)
Stability of HE4 and CA125 in blood samples from patients diagnosed with ovarian cancer (2014) (11)
Inclination of the infraorbital canal studied on dry skulls expresses the maxillary growth pattern: a new contribution to the understanding of change in inclination of ectopic canines during puberty (2009) (11)
Cetuximab every second week with irinotecan in patients with metastatic colorectal cancer refractory to 5-FU, oxaliplatin, and irinotecan: KRAS mutation status and efficacy. (2010) (11)
Influence of mesonephros on foetal and neonatal rabbit gonads. I. Sex-steroid release by the testis in vitro. (1982) (11)
Pre-analytical variables of circulating cell-free nucleosomes containing 5-methylcytosine DNA or histone modification H3K9Me3 (2016) (11)
Investigating intra-tumor heterogeneity and expression gradients of miR-21, miR-92a and miR-200c and their potential of predicting lymph node metastases in early colorectal cancer. (2016) (11)
Association of CD31 and p53 With Survival of Ovarian Cancer Patients (2019) (11)
Chemoradiation-induced changes in serum CEA and plasma TIMP-1 in patients with locally advanced rectal cancer. (2010) (11)
Limited prognostic value of tissue protein expression levels of cyclin E in Danish ovarian cancer patients: from the Danish ‘MALOVA’ ovarian cancer study (2012) (11)
Preoperative concentrations of suPAR and MBL proteins are associated with the development of pneumonia after elective surgery for colorectal cancer. (2006) (11)
Tissue Inhibitor of Metalloproteinase-1 Is Confined to Tumor-Associated Myofibroblasts and Is Increased With Progression in Gastric Adenocarcinoma (2016) (11)
Saliva and plasma TIMP-1 in patients with colorectal cancer: a prospective study (2012) (11)
Changes in preoperative characteristics in patients undergoing radical prostatectomy – a 16-year nationwide analysis (2014) (10)
Ovarian Cancer and Comorbidity: Is Poor Survival Explained by Choice of Primary Treatment or System Delay? (2017) (10)
Development and validation of a prognostic model for recurrent glioblastoma patients treated with bevacizumab and irinotecan (2016) (10)
Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40 (2020) (10)
Discovery and validation of a colorectal cancer classifier in a new blood test with improved performance for high-risk subjects (2017) (10)
Serological biomarkers in triage of FIT-positive subjects? (2017) (10)
Gender differences in patterns of second premolar agenesis observed in 4,756 individuals (2013) (10)
Genetically different cell subpopulations in hydatidiform moles. A study of three cases by RFLP, flow cytometric, cytogenetic, HLA, and morphologic analyses. (1989) (10)
Soluble Interleukin-7 receptor levels and risk of acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation. (2017) (10)
Prognostic value of serum YKL-40 in stage IIB-III melanoma patients receiving adjuvant interferon therapy. (2010) (9)
Intact and cleaved plasma soluble urokinase receptor in patients with metastatic colorectal cancer treated with oxaliplatin with or without cetuximab (2015) (9)
Annexin A2 and S100A10 as Candidate Prognostic Markers in Epithelial Ovarian Cancer (2019) (9)
C4.4A gene ablation is compatible with normal epidermal development and causes modest overt phenotypes (2016) (9)
Randomised feasibility study of a more liberal haemoglobin trigger for red blood cell transfusion compared to standard practice in anaemic cancer patients treated with chemotherapy (2018) (9)
Gel-Based Proteomics of Clinical Samples Identifies Potential Serological Biomarkers for Early Detection of Colorectal Cancer (2019) (9)
Flow cytometric DNA analysis of breast cancers with predominance of carcinoma in situ: a comparison of the premalignant and malignant components. (1995) (9)
Flow Cytometric DNA index, G-band Karyotyping, and Comparative Genomic Hybridization in Detection of High Hyperdiploidy in Childhood Acute Lymphoblastic Leukemia (2006) (9)
Serum YKL-40 levels in patients with cervical cancer are elevated compared to patients with cervical intraepithelial neoplasia and healthy controls. (2006) (9)
Low-level resistance to camptothecin in a human small-cell lung cancer cell line without reduction in DNA topoisomerase I or drug-induced cleavable complex formation. (1998) (9)
Increased serological cancer-associated biomarker levels at large bowel endoscopy and risk of subsequent primary cancer† (2016) (9)
Chronic lymphocytic leukaemia of T cell origin. Clinical variation possibly due to involvement of different T lymphocyte subpopulations. (2009) (9)
Underpinning the repurposing of anthracyclines towards colorectal cancer: assessment of topoisomerase II alpha gene copy number alterations in colorectal cancer (2013) (9)
Serum YKL‐40 and uterine artery Doppler – a prospective cohort study, with focus on preeclampsia and small‐for‐gestational‐age (2014) (9)
First danish single-institution experience with radical prostatectomy: impact of surgical margins on biochemical outcome (2012) (9)
Comorbidity is an independent prognostic factor in women with uterine corpus cancer: a nationwide cohort study (2014) (8)
Concentrations of VEGF and VEGFR1 in paired tumor arteries and veins in patients with rectal cancer. (2004) (8)
Loss of E-cadherin as Part of a Migratory Phenotype in Melanoma Is Associated With Ulceration (2017) (8)
Reduced variation in the clonogenic assay obtained by standardization of the cell culture conditions prior to drug testing on human small cell lung cancer cell lines (1989) (8)
Biomarkers in tissue from patients with upper gastrointestinal cancers treated with erlotinib and bevacizumab (2011) (8)
Serum tetranectin is a significant prognostic marker in ovarian cancer patients (2010) (8)
Prognostic significance of circulating intact and cleaved forms of urokinase plasminogen activator receptor in inoperable chemotherapy treated cholangiocarcinoma patients. (2014) (8)
Survival and toxicity in patients with disseminated germ-cell cancer above 40 years of age. (2013) (8)
Radical prostatectomy in clinically localized high-risk prostate cancer: Outcome of 231 consecutive patients (2013) (8)
Gene expression profile association with poor prognosis in epithelial ovarian cancer patients (2021) (8)
Craniofacial morphology of the frontonasal segment in patients with one or two macrodontic maxillary central incisors. (2013) (7)
In vitro evaluation of a new nitrosourea, TCNU, against human small cell lung cancer cell lines (2004) (7)
Serum Cathepsin H as a Potential Prognostic Marker in Patients with Colorectal Cancer (2004) (7)
Doxorubicin sensitivity pattern in a panel of small-cell lung-cancer cell lines: correlation to etoposide and vincristine sensitivity and inverse correlation to carmustine sensitivity (2004) (7)
DNA ploidy analysis in breast carcinoma. Comparison of unfixed and fixed tissue analyzed by image and flow cytometry. (1997) (7)
Triage for selection to colonoscopy? (2018) (7)
Evaluation of a panel of tumor-specific differentially-methylated DNA regions in IRF4, IKZF1 and BCAT1 for blood-based detection of colorectal cancer (2021) (7)
TIMP-1 and CEA as biomarkers in third-line treatment with irinotecan and cetuximab for metastatic colorectal cancer (2015) (7)
Blood-based Biomarkers at Large Bowel Endoscopy and Prediction of Future Malignancies (2015) (7)
Differences in Regional Diagnostic Strategies and in Intended Versus Actual First-Line Treatment of Patients With Advanced Ovarian Cancer in Denmark (2014) (7)
Pre-Treatment Prediction of Chemoresistance in Second-Line Chemotherapy of Ovarian Carcinoma: Value of Serological Tumor Marker Determination (Tetranectin, YKL-40, CASA, CA 125) (2006) (7)
Outcome of Bevacizumab Therapy in Patients with Recurrent Glioblastoma Treated with Angiotensin System Inhibitors (2018) (7)
The concentration of the cleaved suPAR forms in pre‐ and postoperative plasma samples improves the prediction of survival in colorectal cancer: A nationwide multicenter validation and discovery study (2019) (6)
Prognostic utility of serum YKL-40 in patients with cervical cancer (2020) (6)
TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: A potential novel approach to the treatment of metastatic colorectal cancer (2016) (6)
Optimized Biobanking Procedures for Preservation of RNA in Tissue: Comparison of Snap-Freezing and RNAlater-Fixation Methods. (2019) (6)
Early postnatal development of the mandibular permanent first molar in infants with isolated cleft palate. (2012) (6)
Tissue inhibitor of metalloproteinase‐1 levels in plasma from tumour arteries and veins of patients with rectal cancer (2007) (6)
An explorative analysis of ERCC1-19q13 copy number aberrations in a chemonaive stage III colorectal cancer cohort (2013) (6)
Prognostic Significance of Interleukin-7 Receptor-Alpha Gene Polymorphisms in Allogeneic Stem Cell Transplantation: a Confirmatory Study. (2009) (6)
Recurrent epithelial ovarian cancer: validation and improvement of an established prognostic index. (2005) (6)
Cell cycle analysis of estrogen stimulated growth of the human breast cancer cell line, MCF-7. (1986) (6)
Noncoding RNA (ncRNA) Profile Association with Patient Outcome in Epithelial Ovarian Cancer Cases (2020) (6)
Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)—validation in two independent cohorts (2018) (6)
Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study (2018) (6)
Early biochemical recurrence, urinary continence and potency outcomes following robot-assisted radical prostatectomy (2014) (6)
Comparability of prostate trials (1993) (6)
A Prognostic Model for Glioblastoma Patients Treated With Standard Therapy Based on a Prospective Cohort of Consecutive Non-Selected Patients From a Single Institution (2021) (5)
Markers of angiogenesis and epidermal growth factor receptor signalling in patients with pancreatic and gastroesophageal junction cancer. (2011) (5)
Prognostic factors for relapse in patients with clinical stage I testicular cancer: protocol for a Danish nationwide cohort study (2019) (5)
Prognostic importance of DNA flow cytometrical, histopathological and immunohistochemical parameters in neuroblastomas (2005) (5)
Helicobacter pylori Colonization Drives Urokinase Receptor (uPAR) Expression in Murine Gastric Epithelium During Early Pathogenesis (2020) (5)
Biological variations in plasma VEGF and VEGFR-1 may compromise their biomarker value in colorectal cancer (2010) (5)
Screening for the fragile X: how many cells should we analyse? (1988) (5)
Carboplatin treatment of antiestrogen-resistant breast cancer cells. (2012) (5)
Classification of Ovarian Cancer Surgery Facilitates Treatment Decisions in a Gynecological Multidisciplinary Team (2017) (5)
Erratum to: Fluorescence spectroscopy as a potential metabonomic tool for early detection of colorectal cancer (2012) (5)
KRAS, BRAF mutations, and HER2 expression in patients operated for pancreatic adenocarcinomas. (2010) (5)
Expression of Secretory Phospholipase A2 Group IIa in Breast Cancer and Correlation to Prognosis in a Cohort of Advanced Breast Cancer Patients (2020) (5)
Levels of tissue inhibitor of metalloproteinases 1 in plasma and urine from patients with bladder cancer. (2006) (5)
Consumption of the Epidermis: A Suggested Precursor of Ulceration Associated With Increased Proliferation of Melanoma Cells (2015) (5)
Triage May Improve Selection to Colonoscopy and Reduce the Number of Unnecessary Colonoscopies (2020) (5)
Circadian‐Stage Dependence of Methotrexate In A Keratinized Epithelium. an in‐vivo Study Using Flow Cytometry On the Hamster Cheek Pouch Epithelium (2008) (4)
Health-related quality of life and caregiver perspectives in glioblastoma survivors: a mixed-methods study (2019) (4)
ABCG2 Protein Levels and Association to Response to First-Line Irinotecan-Based Therapy for Patients with Metastatic Colorectal Cancer (2020) (4)
[Local recurrence and survival after mesorectal excision for rectal cancer--secondary publication]. (2005) (4)
Bacterial antigen induced release of soluble vascular endothelial growth factor (VEGF) and VEGFR1 before and after surgery (2005) (4)
Pre- and Perioperative Inflammatory Biomarkers in Older Patients Resected for Localized Colorectal Cancer: Associations with Complications and Prognosis (2021) (4)
Prognostic impact of histological review of high-grade endometrial carcinomas in a large Danish cohort (2021) (4)
Cancer Cathepsin D and Poor Prognosis in Primary Human Breast 52 , 000 r M Association between High Concentrations of Updated (2006) (4)
Serum YKL-40 in risk assessment for colorectal cancer: A prospective study of 4496 subjects at risk of colorectal cancer (2014) (4)
Limited prognostic value of tissue protein expression levels of BCl‐2 in Danish ovarian cancer patients: from the Danish ‘MALOVA’ ovarian cancer study (2010) (4)
Flow Cytometric Bivariate Analysis of DNA and Cytokeratin in Colorectal Cancer (2002) (4)
YKL-40 protein expression in cancer cells and macrophages in colorectal cancer (2005) (4)
Evaluation of algorithm development approaches: Development of biomarker panels for early detection of colorectal lesions. (2019) (4)
Human skin fibroblast in vitro tetraploidy. Flow cytometric DNA assay used to confirm metaphase assay in patients with various colonic diseases. (1989) (4)
Syncytin is involved in cancer-endothelial cell fusions (2006) (4)
Age‐stratified reference intervals unlock the clinical potential of circulating cell‐free DNA as a biomarker of poor outcome for healthy individuals and patients with colorectal cancer (2020) (4)
Flow cytometry and sorting of meiotic prophase cells of female rabbits. (1986) (4)
Tumor-induced growth-inhibitory activity isolated from the Yoshida ascites fluid by extraction with methanol. (1984) (3)
Early Detection and Recurrence of Colorectal Adenomas by Combination of Eight Cancer-Associated Biomarkers in Plasma (2020) (3)
Biomarkers for predicting complete debulking in ovarian cancer: lessons to be learned. (2014) (3)
[Serological markers of colorectal cancer]. (2005) (3)
A method for flow cytometric cell cycle analysis of normal and psoriatic human epidermis based on a detergent/citric acid technique for suspension of nuclei (1985) (3)
The prognostic value of polycomb group protein B‐cell‐specific moloney murine leukemia virus insertion site 1 in stage II colon cancer patients (2016) (3)
KRAS mutations and relation to prognosis in patients operated for localized pancreatic cancer and other periampullary cancers. (2009) (3)
Early detection of recurrence after curative resection for colorectal cancer – obstacles when using soluble biomarkers? (2013) (3)
Serum YKL-40 in risk assessment for colorectal cancer. A population based, prospective study of 4,987 subjects at risk of colorectal cancer (2008) (3)
Comparability of EORTC and DAPROCA Studies in Advanced Prostatic Cancer (1990) (3)
Circulating Forms of Urokinase-Type Plasminogen Activator Receptor in Plasma Can Predict Recurrence and Survival in Patients with Urothelial Carcinoma of the Bladder (2021) (3)
[Sigmoidoscopy as primary examination in patients with bowel symptoms]. (2001) (3)
Introducing PET/CT in Cervical Cancer Staging Procedures Leads to Stage Migration and Selection Bias (2014) (3)
Plasma IL-8 and ICOSLG as prognostic biomarkers in glioblastoma (2021) (3)
Clean Colorectum at Diagnostic Colonoscopy: Subsequent Detection of Extracolonic Malignancies by Plasma Protein Biomarkers? (2018) (3)
Abstract P3-06-32: Topoisomerase 1 gene copy aberration is a frequent finding in clinical breast cancer samples (2012) (3)
Serum tetranectin as a preoperative indicator for postoperative complications in Danish ovarian cancer patients. (2010) (3)
Evaluation of analytical accuracy of HER2 status in patients with breast cancer (2020) (3)
The Plasminogen Activation System as a Source of Prognostic Markers in Cancer (2008) (3)
Validation of Nu.Q™ colorectal cancer screening triage test to identify FIT positive individuals at low risk of screen relevant neoplasia. (2017) (3)
Multigene expression profile for predicting efficacy of cisplatin and vinorelbine in non-small cell lung cancer (2016) (3)
Prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) in Danish patients with recurrent epithelial ovarian cancer (REOC) (2006) (3)
Maxillary Canine Ectopia and Maxillary Canine-Premolar Transposition are Associated with Deviations in the Maxilla (2018) (3)
Biomarkers in Recurrent Grade III Glioma Patients Treated with Bevacizumab and Irinotecan (2018) (3)
MicroRNA characteristics in epithelial ovarian cancer (2021) (3)
Prognostic significance of liver parameters at 1-year follow-up in children and adults undergoing myeloablative allogeneic stem cell transplantation (2015) (3)
Is tissue CA125 expression in epithelial ovarian adenocarcinoma heterogenic? (2013) (2)
High resolution DNA flow cytometry of boar sperm cells in identification of boars carrying cytogenetic aberrations. (2004) (2)
The serological markers TIMP-1, PAI-1, MASP-2 and CRP are independent predictors of colorectal cancer-specific death. (2006) (2)
MEDICAL RADIATION THERAPIES (2013) (2)
273 Is PSA doubling time reliable as a progression risk criterion for patients with low-risk prostate cancer in an active surveillance programme? (2013) (2)
Combined plasma C‐reactive protein, interleukin 6 and YKL‐40 for detection of cancer and prognosis in patients with serious nonspecific symptoms and signs of cancer (2022) (2)
Balloon catheters versus vaginal prostaglandins for labour induction (CPI Collaborative): an individual participant data meta-analysis of randomised controlled trials (2022) (2)
Fulvestrant response prediction from transcriptome data obtained from primary breast cancer biopsies. (2016) (2)
898 DEVELOPMENT OF BLOOD-BASED, CANCER-ASSOCIATED BIOMARKERS FOR EARLY DETECTION OF COLORECTAL CANCER: SIGNIFICANT DIFFERENCES BETWEEN RESULTS FROM SYMPTOMATIC AND SCREENING SUBJECTS. (2020) (2)
Preoperative plasma vitamin D in patients with localized colorectal cancer: Age-dependent association with inflammation, postoperative complications, and survival. (2022) (2)
DNA ploidy and S-phase fraction in medullary carcinoma of the breast -a flow cytometric analysis using archival material (2004) (2)
Modulation of the effect of l-ß-D-Arabinofuranosylcytosine based on changes of Cytidine Deaminase activity in Hl60 Cells (1990) (2)
Assessment of the Biological Variation of Plasma Tissue Inhibitor of Metalloproteinases-1 (2008) (2)
High serum YKL-40, but not plasma VEGF and serum HER2, as a prognostic biomarker of short survival in patients with metastatic colorectal cancer (2007) (2)
Pre-treatment prediction of chemoresistance in second-line chemotherapy of ovarian carcinoma: value of serological tumor marker determination (tetranectin, YKL-40, CASA, CA 125). (2006) (2)
Early detection of colorectal neoplasia: application of a blood-based serological protein test on subjects undergoing population-based screening (2020) (2)
A consistent shift in VEGF determinations between two different ELISA batch numbers (2003) (2)
DNA-aneuploidy in 46,XX hydatidiform moles. (1987) (2)
Urokinase‐Type Plasminogen Activator, Its Receptor and Inhibitor as Biomarkers in Cancer (2012) (1)
Growth patterns of liver metastases as compared to resected tumors of the same colorectal cancer patients. (2012) (1)
Intratumoral neutrophils, plasmacytoid dendritic cells, and pSTAT3 in AJCC stage I/II melanoma prognosis. (2011) (1)
Plasma levels of intact and cleaved urokinase plasminogen activator receptor (uPAR) in men with clinically localised prostate cancer (2017) (1)
Association of serum level of YKL-40 in patients with squamous cell carcinoma of the head and neck with survival. (2006) (1)
Prognostic impact of preoperative plasma tissue inhibitor of metalloproteinase 1 (pTIMP-1) in colorectal cancer (CRC) patients (Pts): A pooled analysis of 1,024 stage II/III pts. (2012) (1)
Low‐dose chemotherapy delays relapse of a dominated and resistant sub‐population in a heterogeneous human sclc xenograft in nude mice (1994) (1)
Second international congress of hormones and cancer186 Effects of the antiestrogen tamoxifen on the cell cycle kinetics of the human mammary carcinoma cell line, MCF-7 (1983) (1)
Benefit of EGFR-inhibition therapy for metastatic colorectal cancer patients with KRAS-mutated tumors and high plasma TIMP-1 level: Results from the NORDIC VII study. (2014) (1)
Prediction of fulvestrant efficacy in patients with advanced breast cancer: retrospective-prospective evaluation of the predictive potential of a multigene expression assay (2019) (1)
Circadian variation of DNA replication in hamster cheek pouch epithelium analysed by tritiated thymidine labelling, flow sorting and autoradiography: no resting S phase cells in the normal epithelium (1996) (1)
Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution (2013) (1)
Pretreatment plasma concentrations of YKL-40 and IL-6 in patients with pancreatic cancer: Potential diagnostic and prognostic biomarkers. (2013) (1)
Plasma YKL-40 as a biomarker for poor prognosis in patients with metastatic colorectal cancer treated with 3. line cetuximab and irinotecan (2016) (1)
Classification of Ovarian Cancer Surgery Facilitates Treatment Decisions in a Gynecological Multidisciplinary Team. (2017) (1)
Renal impairment and late toxicity in germ-cell cancer survivors. (2014) (1)
Optimizing Screening for Colorectal Cancer: An Algorithm Combining Fecal Immunochemical Test, Blood-Based Cancer-Associated Proteins and Demographics to Reduce Colonoscopy Burden. (2023) (1)
Independent prognostic value of plasma tissue inhibitor of metalloproteinases-1 (TIMP-1) in colorectal cancer: A prospective validation study (2008) (1)
Long-term survival update of the Scandinavian Prostate Cancer Group 6 study: Bicalutamide 150 mg daily versus placebo in hormone-naïve, non-metastatic prostate cancer. (2015) (1)
Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma (2020) (1)
117 Characterization of high and low level resistance to topoisomerase I poisons in small cell lung cancer cells resistant to camptothecin and topotecan (1997) (1)
Doxorubicin response prediction in neoadjuvant breast cancer therapy. (2019) (1)
Prediction of exemestane benefit in patients with advanced breast cancer based on diagnostic biopsy mRNA analysis. (2017) (1)
Validation of the predictive value of tissue inhibitor of metalloproteinases-1 for the response to first-line chemotherapy in metastatic breast cancer. (2009) (1)
Abstract B3: Prognostic and predictive biomarkers in recurrent WHO grade 3 malignant glioma patients treated with bevacizumab and irinotecan (2015) (1)
Abstract P5-04-13: Triple negative breast cancer: Expression of immuno-oncology treatment targets and prevalence of tumor infiltrating lymphocytes in paired primary tumors and metastases (2020) (1)
7 Histone deacetylase 1, 2, 6 and acetylated histone H4 in diffuse large B-cell lymphomas (2008) (1)
144 PROGNOSTIC IMPACT OF U-PAR IN METASTATIC PROSTATE CANCER (2010) (1)
P1020 Cleaved forms of the upa receptor in plasma have diagnostic potential and predict postoperative survival in patients with ovarian cancer (2009) (1)
An explorative analysis of ERCC1-19q13 copy number aberrations in a chemonaive stage III colorectal cancer cohort (2013) (1)
Development of a prognostic model for glioblastoma patients treated with standard therapy: A prospective study from a single institution. (2018) (1)
ER and PgR in breast cancer, 1993, more than a question of positivity versus negativity (1993) (0)
Increasing use of radical prostatectomy for lower-risk prostate cancer in Denmark (2014) (0)
PATH-21. ANGIOTENSINOGEN GENE SILENCING PREDICTS BEVACIZUMAB RESPONSE IN RECURRENT GLIOBLASTOMA PATIENTS (2018) (0)
147 The expression of uPAR may be a prognostic marker in urothelial neoplasia of the bladder (2014) (0)
Wound-linked neutrophil re sponse associates with increased proliferation in ulcerated melanoma (2014) (0)
Growth pattern of colorectal liver metastasis as a marker of recurrence risk (2015) (0)
Gender differences in patterns of second premolar agenesis observed in 4,756 individuals (2013) (0)
Reducing workload in malignant melanoma sentinel node examination: a national study of pathology reports from 507 melanoma patients (2023) (0)
Serum levels of mannose binding lectin are associated with carotid intima-media thickness in patients with rheumatoid arthritis (2009) (0)
427 Urokinase plasminogen activator receptor (uPAR) assessment in localized-, hormone naïve-, and castration resistant prostate cancer (2015) (0)
Increased cancer-associated protein biomarker levels at bowel endoscopy and risk of extra-colonic primary cancer. (2015) (0)
Abstract 2342: Prognosis for patients with adenocarcinomas of lower esophagus, gastro-esophageal junction and cardia can be directly evaluated by immunohistochemistry of uPAR (2010) (0)
PP 88 C4.4A as a biomarker for poor prognosis in non-small cell lung cancer patients with adenocarcinomas (2011) (0)
Angiotensinogen gene silencing to predict bevacizumab response in recurrent glioblastoma patients. (2018) (0)
Tamoxifen and castration in addition to cytotoxics in the treatment of premenopausal patients with metastatic breast cancer : A phase III trial of CAF + castration vs CAF + castration + Tamoxifen (1992) (0)
An explorative analysis of TOP1 copy number alterations in a chemonaive stage III CRC patient cohort. (2012) (0)
84 Cell proliferation in homozygous hydatidiform moles estimated by flow cytometry (1989) (0)
68 Impairment of post-lactational involution of the mammary gland in mice deficient for the plasminogen gene (1997) (0)
PP63 Predictive markers in patients with upper gastrointestinal (GI) cancers treated with erlotinib and bevacizumab in a multicenter phase II trial (2009) (0)
First Danish single-institution experience with Radical Prostatectomy: Impact of site and number of surgical margins on biochemical outcome (2012) (0)
Abstract 1912: An explorative analysis ofERCC1/ERCC4copy number alterations in a chemonaive stage III colorectal cancer patient cohort. (2013) (0)
Evaluation of a panel of tumor-specific differentially-methylated DNA regions in IRF4, IKZF1 and BCAT1 for blood-based detection of colorectal cancer (2021) (0)
PP 76 Biomarker discovery using multiplexed in solution proximity extension assays: a case–control study for early detection of colorectal cancer (2011) (0)
819PHYPERTENSION, NEUTROPENIA, THROMBOCYTOPENIA, NORMAL SODIUM AND LDH WITHIN THE FIRST 12 WEEKS OF TREATMENT AS INDEPENDENT BIOMARKERS OF OUTCOME IN METASTATIC RENAL CELL CARCINOMA (MRCC). (2014) (0)
Serum-based multiplex protein assay for early detection of colorectal cancer and precancerous lesions in a FIT positive population. (2020) (0)
Plasma levels of TIMP-1 in chemo-naive patients with metastatic colorectal cancer treated with first-line FLOX with or without cetuximab: Results from the Nordic VII Study. (2013) (0)
Syddansk Universitet TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells A potential novel approach to the treatment of metastatic colorectal cancer (2016) (0)
Versatile multigene expression biomarker for predicting clinical platinum sensitivity in non-small cell lung cancer (NSCLC) and ovarian cancer (OC). (2015) (0)
Changes in serum P1NP, BAP, CTX-1, and YKL-40 following hormonal treatment for metastatic prostate carcinima are related to survival. (2006) (0)
Abstract 4306: A prognostic model for clinical response to bevacizumab in recurrent glioblastoma multiforme (2015) (0)
[The prognostic significance of progesterone receptor level in endometrial cancer]. (1997) (0)
Early detection of colorectal cancer: A proteomic screening study for plasma biomarkers. (2012) (0)
MUCOSAL EXPRESSION OF GENES PI3, ANXA1, AND VDR DESCRIMINATES CROHNS DISEASE FROM ULCERATIVE COLITIS IN INFLAMMATORY BOWEL DISEASE PATIENTS (2023) (0)
TOP1 gene copy number in stage III colorectal cancer (CRC) samples: Association to prognosis. (2012) (0)
996 NATION-WIDE ANALYSIS OF SURVIVAL AFTER RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER IN DENMARK 1995-2011 (2013) (0)
DNA aneuploidy in sarcoid granuloma. (1989) (0)
Levels of Tissue Inhibitor of Metalloproteinases 1 in Plasma and Urine from Patients with Bladder Cancer (2006) (0)
Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer—a clinical biomarker discovery and validation study (2019) (0)
Utility of Sentinel Lymph Node Biopsy in Patients with High-Risk Squamous Cell Carcinoma (2014) (0)
In reply to Maletz et al. (2013) (0)
Increasing number of men undergo radical prostatectomy for lower-risk prostate cancer in Denmark: A 16-year nation-wide analysis (2013) (0)
High serum YKL-40 level in patients with extended small cell lung cancer is related to short survival (2004) (0)
PP 89 The prognostic value of plasma TIMP-1 in resectable colorectal cancer: a prospective validation study (2011) (0)
MTR-18PREDICTIVE BIOMARKERS OF BEVACIZUMAB RESPONSE IN RECURRENT GLIOBLASTOMA PATIENTS (2015) (0)
[Flow cytometric analysis of DNA and its use in clinical and experimental oncology]. (1991) (0)
Su1505 The Prognostic Value of Plasma TIMP-1 in Resectable Colorectal Cancer: A Prospective Validation Study (2012) (0)
PrimaryTumor Levels ofTissue Inhibitor of Metalloproteinases-1 Are Predictive of Resistance to Chemotherapy in Patients with Metastatic Breast Cancer (2006) (0)
Differences in the efficacy of TNF-inhibitors are supported by sensitivity analyses (2010) (0)
Correlation of plasma TIMP-1 levels and disease-free survival in primary colorectal cancer independent of serum CEA levels. (2016) (0)
Positron emission tomography/computed tomography for early treatment response evaluation in metastatic colon cancer. (2014) (0)
Data fusion in metabolomic cancer diagnostics (2012) (0)
Abstract A25: Predictive biomarkers for bevacizumab response in recurrent glioblastoma patients (2015) (0)
Subject Index Vol. 27, 2006 (2006) (0)
Tu2001 A NOVEL PANEL OF 92 BLOOD-BASED BIOMARKERS FOR THE DETECTION OF COLORECTAL CANCER AND HIGH-RISK ADENOMAS IN 784 SYMPTOMATIC SUBJECTS. (2020) (0)
CEG_A_251633 273..284 (2020) (0)
University of Southern Denmark Abcg2 protein levels and association to response to first-line irinotecan-based therapy for patients with metastatic colorectal cancer Palshof, (2020) (0)
Highlights from the pharmacology and molecular mechanisms group annual meeting (2007) (0)
Independent clinical validation of a gene expression profile to predict benefit of 5-FU in metastatic colorectal cancer (2019) (0)
Prospective blinded evaluation predicting efficacy of adjuvant cisplatinum and vinorelbine by a multigene assay after radical surgery in non-small cell lung cancer. (2016) (0)
Levels of tissue inhibitor of metalloproteinases 1 in plasma and urine from patients with bladder cancer. (2006) (0)
Biomarkers of inflammation and YKL-40 in patients with metastatic colorectal cancer are associated with short survival (2008) (0)
23 A comparative study of Tissue Inhibitor of Metalloproteinases-1 levels in plasma and tumour tissue from patients with primary breast cancer and in plasma from patients with metastatic breast cancer (2008) (0)
Lectin pathway proteins in colorectal cancer (2013) (0)
P11.32.A EGFR expression and non-methylated MGMT predict distant recurrence in glioblastoma patients treated with standard therapy (2022) (0)
A novel proteomics biomarker panel as a diagnostic tool for patients with ovarian cancer. (2010) (0)
Flow cytometric methods for DNA aneuploidy and cell cycle analysis (1988) (0)
P024 Interim analysis of uPAR positive cells in the microenvironment of human urothelial neoplasia of the bladder – A possible prognostic marker (2013) (0)
A nation-wide analysis of survival after radical prostatectomy in Denmark 1995 to 2011 (2013) (0)
High serum YKL-40 level in patients with extended small cell lung cancer is related to short survival. (2004) (0)
Abstract B21: Macrophages and T cell infiltration in colorectal liver metastases according to growth pattern (2013) (0)
ACTR-26. TOXICITY AND EFFICACY OF LOMUSTINE PLUS BEVACIZUMAB IN RECURRENT GLIOBLASTOMA PATIENTS (2017) (0)
Gynecological Cancers: A Challenge of Individualized Therapy in the Adjuvant and Palliative Setting (2015) (0)
Abstract B14: uPAR expression in the microenvironment of human urothelial neoplasia of the bladder is associated with invasive behavior and increases significantly with T-stage and grade (2013) (0)
Variations in serum P1NP, BAP and YKL-40 levels after start of treatment for advanced prostate cancer and the relation to prognosis (2004) (0)
Abstract B02: Blood-based epigenetic profiling of circulating cell free nucleosomes in 2000 FIT positive individuals: A novel approach to colorectal cancer detection (2017) (0)
EPID-06. IMMUNE-RELATED PLASMA BIOMARKERS IN GLIOBLASTOMA (2019) (0)
A high serum level of YKL-40 in patients with cervical cancer is associated with short survival (2007) (0)
UP-02.168 Serum Testosterone as a Predictor of Biochemical Failure after Radical Prostatectomy in Patients with Localized Prostate Cancer (2011) (0)
Correlation between leukocyte-associated plasma proteins and white cell differential count. (1991) (0)
Abstract 5310: Prognostic and predictive biomarkers of clinical response to Bevacizumab in recurrent WHO grade 3 malignant glioma patients (2015) (0)
Prognostic and predictive value of cathepsin X in serum from colorectal cancer patients (2014) (0)
Tu1674 – Serological Biomarker Levels At Diagnostic Colonoscopy; Risk of Subsequent Primary Malignancy (2019) (0)
Activated and cycling lymphocytes in benign dermal lymphocytic infiltrates including psoriatic skin lesions (2004) (0)
Variations in serum P1NP, BAP and YKL-40 levels after start of treatment for advanced prostate cancer and the relation to prognosis. (2004) (0)
99 High preoperative blood levels of urokinase plasminogen activator receptor (UPAR) and carcinoembryonic antigen (CEA) defines a group of colorectal cancer patients with poor prognosis (1997) (0)
PP 79 Low levels of cleaved urokinase receptor in plasma from healthy individuals (2011) (0)
EPID-28PROGNOSTIC AND PREDICTIVE BIOMARKERS IN RECURRENT WHO GRADE 3 GLIOMA PATIENTS TREATED WITH BEVACIZUMAB AND IRINOTECAN (2015) (0)
Mr-004. A Model For Survival From Glioblastoma Multiforme In A Cohort Of Consecutive Non-selected Patients From A Single Institution (2013) (0)
Detection of Extra-Colonic Cancers in Subjects, who have Clean Large Bowel at Diagnostic Colonoscopy: Application of Organ Specific Plasma Protein Biomarkers (2017) (0)
Evaluation of a 92 multiplex protein panel in detection of colorectal cancer and high-risk adenoma in 784 symptomatic individuals. (2021) (0)
Tu1819 COMPLEMENTARY HYPERMETHYLATED CTDNA BIOMARKERS FOR EARLY DETECTION OF COLORECTAL NEOPLASIA (2020) (0)
Su1782 - Upar(I) and type IV Collagen Outperform CEA as Prognostic Biomarker in Primary Colorectal Cancer (2018) (0)
Fluorescence spectroscopy as a potential metabonomic tool for early detection of colorectal cancer (2011) (0)
Evaluation of drug-specific multigene markers to predict aromatase inhibitor efficacy in advanced breast cancer: a cohort study from Danish Breast Cancer Cooperative Group (2019) (0)
Outcome of cetuximab plus irinotecan in relation to RAS and BRAF mutational status in patients with colorectal cancer prior treated with a fluoropyrimidine, oxaliplatin and irinotecan. (2016) (0)
Detection of serological biomarkers by proximity extension assay for detection of colorectal neoplasias in symptomatic individuals (2013) (0)
870 Increased Soluble Cancer-Associated Biomarker Levels at Colonoscopy and Subsequent Long-Term Risk of Primary Cancer (2015) (0)
Pharmacogenetic polymorphisms in folate metabolism affect toxicity after high dose methotrexate in childhood acute lymphoblastic leukemia (2012) (0)
P1 Urokinase-type plasminogen activator receptor variants in serum and plasma of women with various breast lesions (2007) (0)
MC13-0028 Prognostic significance of serum levels of intact and cleaved forms of urokinase plasminogen activator receptor (suPAR) in patients with inoperable cholangiocarcinoma (2013) (0)
Serological cancer-associated protein biomarker levels at bowel endoscopy: Increased risk of subsequent primary malignancy. (2022) (0)
Serum Il-6 as a prognostic biomarker in patients with stage IIB-III melanoma (2012) (0)
EPID-13. IDENTIFICATION OF PROGNOSTIC MARKERS IN A COHORT OF CONSECUTIVE NON-SELECTED GLIOBLASTOMA PATIENTS RECEIVING STANDARD THERAPY (2019) (0)
PrognosticValue of PINP , BoneAlkaline Phosphatase , CTX-I , andYKL-40 in PatientsWithMetastatic ProstateCarcinoma (2006) (0)
Release of sVEGF and sVEGFR1 from White Blood Cells and Platelets During Surgery and Stimulation with Bacterial Antigens (2004) (0)
Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer on Early Detection of Colorectal (2018) (0)
Su2026 Do Intra-Tumor Expression Levels of miR-200c, miR-21 and miR-92a Indicate High Risk of Metastases in Early Colorectal Cancer? (2016) (0)
A Validated Algorithm for Register-Based Identification of Patients with Relapse of Clinical Stage I Testicular Cancer (2023) (0)
The urokinase plasminogen activator receptor in blood from healthy individuals and patients with cancer Review article (1999) (0)
Preoperative Plasma Plasminogen Activator and Serum C-Reactive Protein Levels in Colorectal Cancer Inhibitor Type- 1 Patients With (2000) (0)
Plasma TIMP-1 in patients with metastatic colorectal cancer treated with first-line oxaliplatin-based therapy with or without cetuximab: Results from the Nordic VII study. (2013) (0)
P17.91CLINICAL VARIABLES SERVE AS PREDICTIVE FACTORS IN A MODEL FOR CLINICAL RESPONSE TO BEVACIZUMAB IN RECURRENT GLIOBLASTOMA MULTIFORME: AN OBSERVATIONAL STUDY OF A COHORT OF CONSECUTIVE NON-SELECTED PATIENTS FROM A SINGLE INSTITUTION (2014) (0)
Serum IL-6 and YKL-40 Levels in Early Rheumatoid Arthritis are Associated with Disease Activity: Treatment Response and Radiograhpic Outcome (2007) (0)
Decline in CA19-9 during chemotherapy predicts survival in four independent cohorts of patients with inoperable cholangiocarcinoma (2014) (0)
Tissue inhibitor of matrix metalloprotease type-1 (TIMP-1) as a marker of cancer. (2000) (0)
106 Association of preoperative plasma PAI-1 and CRP levels in patients with colorectal cancer (1997) (0)
102 Urokinase plasminogen activator receptor in plasma is an independent prognostic variable in patients with colorectal cancer (1997) (0)
Novel blood-based biomarker candidates in screening for colorectal cancer. (2023) (0)
University of Southern Denmark TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells A potential novel approach to the treatment of metastatic colorectal cancer (2016) (0)
Retrospective-prospective blinded evaluation predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort. (2017) (0)
121 MicroRNA-21 is expressed in stroma of colorectal cancers and high levels identified by image analysis predict short disease-free survival in stage II colon cancer patients (2010) (0)
Urokinase plasminogen activator receptor (uPAR) as a novel biomarker in prostate cancer. (2015) (0)
Title : Prognostic and predictive value of cathepsin X in serum from colorectal cancer patients (2014) (0)
Erratum to: Fluorescence spectroscopy as a potential metabonomic tool for early detection of colorectal cancer (2011) (0)
National coverage of biological materials for translational research in the Danish cancerbiobank (RBGB) and of corresponding clinical data in the Danish Gynecological Cancer Database (DGCD) (2020) (0)
[Identification of new ovarian cancer biomarkers with proteomic analyses--the diagnostic tool of the future?]. (2007) (0)
Contents Vol. 27, 2006 (2006) (0)
Neoadjuvant chemotherapy for advanced ovarian cancer might be associated with reduced survival (2013) (0)
910 SEROLOGICAL CANCER-ASSOCIATED PROTEIN BIOMARKER LEVELS AT NEGATIVE BOWEL ENDOSCOPY; INCREASED RISK OF SUBSEQUENT PRIMARY MALIGNANCY? (2020) (0)
Evaluation of an Improved Tissue Inhibitor of Metalloproteinase 1 Dual Monoclonal Sandwich Immunoassay (2006) (0)
Early detection of colorectal cancer from patient blood plasma using microRNA-based q-rt-PCR (2010) (0)
[Screening methods for colorectal cancer can be improved]. (2014) (0)
Discovery and validation of a colorectal cancer classifier in a new blood test with improved performance for high-risk subjects (2017) (0)
Early detection of colorectal neoplasia: Combination of eight cancer-associated blood-based protein biomarkers. (2016) (0)
PATH-28. ANGIOTENSINOGEN PROMOTER METHYLATION TO PREDICT BEVACIZUMAB RESPONSE IN RECURRENT GLIOBLASTOMA PATIENTS (2019) (0)
Carboxypeptidase Cathepsin X Defines a Multifunctional Role of Gamma- Enolase in Cancer (2022) (0)
753 Preoperative levels of the circulating forms of uPAR can predict recurrence and cancer specific death in patients treated with radical cystectomy for UCB (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ib Jarle Christensen?

Ib Jarle Christensen is affiliated with the following schools:

Aarhus University
University of Bergen
McGill University
Norwegian University of Science and Technology
University of Costa Rica
University of Copenhagen

Ib Jarle Christensen's Academic­Influence.com Rankings

Why Is Ib Jarle Christensen Influential?

Ib Jarle Christensen's Published Works

Published Works

What Schools Are Affiliated With Ib Jarle Christensen?

Ib Jarle Christensen's AcademicInfluence.com Rankings